The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC) ...

Johnson & Johnson's IL-23 inhibitor Tremfya has been approved by the FDA as a treatment for Crohn's disease, becoming the first drug in the class available in both intravenous and subcutaneous ...

J&J's Tremfya gets a much-anticipated FDA approval for Crohn's disease, which the company thinks will be key to a renewed phase of sales growth. In a new podcast, web editor Nicole Raleigh speaks ...

Researchers found associations between fatigue and gray matter volume in patients with Crohn’s disease, with a more distinct ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease ...

New research reveals that assessing transmural healing using faecal calprotectin levels and intestinal ultrasonography is ...

Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the digestive tract, often causing abdominal pain, persistent diarrhea, rectal bleeding, weight loss, and fatigue during ...

Learn about celiac disease causes, symptoms, diagnosis, and gluten-free treatment options in this easy-to-understand guide.

Crohn’s Disease is a chronic inflammatory bowel disease, and one-third of patients have no response to initial treatment with tumor necrosis factor (TNF) antagonists. Some patients have a very ...

A Wichita woman with Crohn’s disease has had her treatment reinstated after media attention prompted a reversal of a prior denial that forced her off her original medication.